Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Regulation of skeletal myogenesis by Notch.

Buas MF, Kadesch T.

Exp Cell Res. 2010 Nov 1;316(18):3028-33. doi: 10.1016/j.yexcr.2010.05.002. Epub 2010 May 7. Review.

2.

The Notch effector Hey1 associates with myogenic target genes to repress myogenesis.

Buas MF, Kabak S, Kadesch T.

J Biol Chem. 2010 Jan 8;285(2):1249-58. doi: 10.1074/jbc.M109.046441. Epub 2009 Nov 16.

3.

Inhibition of myogenesis by Notch: evidence for multiple pathways.

Buas MF, Kabak S, Kadesch T.

J Cell Physiol. 2009 Jan;218(1):84-93. doi: 10.1002/jcp.21571.

4.

Functional analysis of Hes-1 in preadipocytes.

Ross DA, Hannenhalli S, Tobias JW, Cooch N, Shiekhattar R, Kadesch T.

Mol Endocrinol. 2006 Mar;20(3):698-705. Epub 2005 Nov 10.

PMID:
16282371
5.

Inhibition of EBF function by active Notch signaling reveals a novel regulatory pathway in early B-cell development.

Smith EM, Akerblad P, Kadesch T, Axelson H, Sigvardsson M.

Blood. 2005 Sep 15;106(6):1995-2001. Epub 2005 May 26.

PMID:
15920012
6.

Notch signaling: the demise of elegant simplicity.

Kadesch T.

Curr Opin Genet Dev. 2004 Oct;14(5):506-12. Review.

PMID:
15380241
7.

Consequences of Notch-mediated induction of Jagged1.

Ross DA, Kadesch T.

Exp Cell Res. 2004 Jun 10;296(2):173-82.

PMID:
15149848
8.
9.

Notch and Schwann cell transformation.

Li Y, Rao PK, Wen R, Song Y, Muir D, Wallace P, van Horne SJ, Tennekoon GI, Kadesch T.

Oncogene. 2004 Feb 5;23(5):1146-52.

PMID:
14762442
11.

Inhibition of p300/CBP by early B-cell factor.

Zhao F, McCarrick-Walmsley R, Akerblad P, Sigvardsson M, Kadesch T.

Mol Cell Biol. 2003 Jun;23(11):3837-46.

12.

The notch intracellular domain can function as a coactivator for LEF-1.

Ross DA, Kadesch T.

Mol Cell Biol. 2001 Nov;21(22):7537-44.

13.
14.

Consequences of Notch-mediated inhibition of the transcription factor E47.

Pear W, Tang Z, DeRocco S, Allman D, Hardy R, Pui J, Xu L, Karnell F, Aster J, Kadesch T.

Cold Spring Harb Symp Quant Biol. 1999;64:33-8. Review. No abstract available.

PMID:
11232304
15.

Murine homologs of deltex define a novel gene family involved in vertebrate Notch signaling and neurogenesis.

Kishi N, Tang Z, Maeda Y, Hirai A, Mo R, Ito M, Suzuki S, Nakao K, Kinoshita T, Kadesch T, Hui C, Artavanis-Tsakonas S, Okano H, Matsuno K.

Int J Dev Neurosci. 2001 Feb;19(1):21-35.

PMID:
11226752
16.

Hematopoietic expression of HOXB4 is regulated in normal and leukemic stem cells through transcriptional activation of the HOXB4 promoter by upstream stimulating factor (USF)-1 and USF-2.

Giannola DM, Shlomchik WD, Jegathesan M, Liebowitz D, Abrams CS, Kadesch T, Dancis A, Emerson SG.

J Exp Med. 2000 Nov 20;192(10):1479-90.

17.

Isolation and characterization of the notch ligand delta4.

Rao PK, Dorsch M, Chickering T, Zheng G, Jiang C, Goodearl A, Kadesch T, McCarthy S.

Exp Cell Res. 2000 Nov 1;260(2):379-86.

PMID:
11035934
18.

Notch signaling: a dance of proteins changing partners.

Kadesch T.

Exp Cell Res. 2000 Oct 10;260(1):1-8. Review. No abstract available.

PMID:
11010805
19.

Notch1 expression in early lymphopoiesis influences B versus T lineage determination.

Pui JC, Allman D, Xu L, DeRocco S, Karnell FG, Bakkour S, Lee JY, Kadesch T, Hardy RR, Aster JC, Pear WS.

Immunity. 1999 Sep;11(3):299-308.

20.

A histone deacetylase corepressor complex regulates the Notch signal transduction pathway.

Kao HY, Ordentlich P, Koyano-Nakagawa N, Tang Z, Downes M, Kintner CR, Evans RM, Kadesch T.

Genes Dev. 1998 Aug 1;12(15):2269-77.

21.

Human deltex is a conserved regulator of Notch signalling.

Matsuno K, Eastman D, Mitsiades T, Quinn AM, Carcanciu ML, Ordentlich P, Kadesch T, Artavanis-Tsakonas S.

Nat Genet. 1998 May;19(1):74-8.

PMID:
9590294
22.

Transcriptional repression of the IL-2 gene in Th cells by ZEB.

Yasui DH, Genetta T, Kadesch T, Williams TM, Swain SL, Tsui LV, Huber BT.

J Immunol. 1998 May 1;160(9):4433-40.

23.

Notch inhibition of E47 supports the existence of a novel signaling pathway.

Ordentlich P, Lin A, Shen CP, Blaumueller C, Matsuno K, Artavanis-Tsakonas S, Kadesch T.

Mol Cell Biol. 1998 Apr;18(4):2230-9.

24.

Decreased immunoglobulin deposition in tumors and increased immature B cells in p53-null mice.

Shick L, Carman JH, Choi JK, Somasundaram K, Burrell M, Hill DE, Zeng YX, Wang Y, Wiman KG, Salhany K, Kadesch TR, Monroe JG, Donehower LA, el-Deiry WS.

Cell Growth Differ. 1997 Feb;8(2):121-31.

25.
26.

Phosphorylation of E47 as a potential determinant of B-cell-specific activity.

Sloan SR, Shen CP, McCarrick-Walmsley R, Kadesch T.

Mol Cell Biol. 1996 Dec;16(12):6900-8.

27.

HMG box-activating factors 1 and 2, two HMG box transcription factors that bind the human Ig heavy chain enhancer.

Stevens S, Ordentlich P, Sen R, Kadesch T.

J Immunol. 1996 Oct 15;157(8):3491-8.

PMID:
8871648
28.

E47 activates the Ig-heavy chain and TdT loci in non-B cells.

Choi JK, Shen CP, Radomska HS, Eckhardt LA, Kadesch T.

EMBO J. 1996 Sep 16;15(18):5014-21.

30.

B-cell-specific DNA binding by an E47 homodimer.

Shen CP, Kadesch T.

Mol Cell Biol. 1995 Aug;15(8):4518-24.

31.

Constitutively expressed Oct-2 prevents immunoglobulin gene silencing in myeloma x T cell hybrids.

Radomska HS, Shen CP, Kadesch T, Eckhardt LA.

Immunity. 1994 Nov;1(8):623-34.

PMID:
7600290
32.
34.

Consequences of heteromeric interactions among helix-loop-helix proteins.

Kadesch T.

Cell Growth Differ. 1993 Jan;4(1):49-55. No abstract available.

35.

DNA binding site preferences and transcriptional activation properties of the Arabidopsis transcription factor GBF1.

Schindler U, Terzaghi W, Beckmann H, Kadesch T, Cashmore AR.

EMBO J. 1992 Apr;11(4):1275-89.

36.

Inhibition of myeloid differentiation by the helix-loop-helix protein Id.

Kreider BL, Benezra R, Rovera G, Kadesch T.

Science. 1992 Mar 27;255(5052):1700-2.

PMID:
1372755
37.

Helix-loop-helix proteins in the regulation of immunoglobulin gene transcription.

Kadesch T.

Immunol Today. 1992 Jan;13(1):31-6. Review.

PMID:
1739428
38.

Repression of immunoglobulin enhancers by the helix-loop-helix protein Id: implications for B-lymphoid-cell development.

Wilson RB, Kiledjian M, Shen CP, Benezra R, Zwollo P, Dymecki SM, Desiderio SV, Kadesch T.

Mol Cell Biol. 1991 Dec;11(12):6185-91.

39.
40.

Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo.

Lassar AB, Davis RL, Wright WE, Kadesch T, Murre C, Voronova A, Baltimore D, Weintraub H.

Cell. 1991 Jul 26;66(2):305-15.

PMID:
1649701
41.
42.
43.

Modulation of the IgH enhancer's cell type specificity through a genetic switch.

Ruezinsky D, Beckmann H, Kadesch T.

Genes Dev. 1991 Jan;5(1):29-37.

44.
45.
46.

Analysis of the human liver/bone/kidney alkaline phosphatase promoter in vivo and in vitro.

Kiledjian M, Kadesch T.

Nucleic Acids Res. 1990 Feb 25;18(4):957-61.

47.

Sequence of the cDNA encoding ITF-2, a positive-acting transcription factor.

Henthorn P, McCarrick-Walmsley R, Kadesch T.

Nucleic Acids Res. 1990 Feb 11;18(3):678. No abstract available.

48.

Sequence of the cDNA encoding ITF-1, a positive-acting transcription factor.

Henthorn P, McCarrick-Walmsley R, Kadesch T.

Nucleic Acids Res. 1990 Feb 11;18(3):677. No abstract available.

49.
50.

Two distinct transcription factors that bind the immunoglobulin enhancer microE5/kappa 2 motif.

Henthorn P, Kiledjian M, Kadesch T.

Science. 1990 Jan 26;247(4941):467-70.

PMID:
2105528

Supplemental Content

Loading ...
Support Center